BioCentury
ARTICLE | Company News

CorBec Pharmaceuticals Inc., Panax deal

August 18, 1997 7:00 AM UTC

The companies extended to Oct. 31 the deadline by which PANX can acquire CorBec, a developer of products that modulate the immune system by manipulating macrophage and mast cell function (see BioCentu...